March 10, 2021 – CVS Health’s Health Trends Report 2021 highlighted three ways to cover high-cost gene therapies. These include:

• Using value-based contracting to reduce the risk for both payers and purchasers
• Identifying high-quality care facilities with the qualifications to oversee drug administration
• Embrace stop-loss insurance to bear the burden of expensive therapies like this